Literature DB >> 24852168

Lipoprotein subclasses and endogenous sex hormones in women at midlife.

Samar R El Khoudary1, Maria M Brooks1, Rebecca C Thurston2, Karen A Matthews2.   

Abstract

The objective of this work was to evaluate the associations between levels of endogenous sex hormones in women at midlife and lipoprotein subclasses. One hundred and twenty women (68 late peri-/postmenopausal and 52 pre-/early perimenopausal) from the Study of Women's Health Across the Nation (Pittsburgh site) were included. Lipoprotein subclasses were quantified using NMR spectroscopy. Participants (57.5% White and 42.5% Black) were 50.4 ± 1.9 years old. Adjusting for age, race, cycle day of blood draw, BMI, physical activity, and alcohol consumption, a negative correlation was found between estradiol (E2) and medium-small LDL particle (LDL-P) concentration (ρ = -0.19, P = 0.04). Further, E2 was positively correlated with HDL particle (HDL-P) size (ρ = 0.22, P = 0.02). For sex hormone binding globulin (SHBG), independent negative correlation was found with total small LDL-P concentration. SHBG was also positively correlated with LDL-P and HDL-P sizes (P < 0.05 for all). For free androgen index (FAI), positive correlations were found with concentrations of total VLDL particles, total LDL-Ps, and total small LDL-Ps. Additionally, FAI was negatively correlated with large HDL-P concentration, and HDL-P and LDL-P sizes (P < 0.05 for all). Lower levels of E2 and SHBG, and higher levels of FAI were associated with a more atherogenic profile of lipoprotein subclasses. Sex hormone levels at midlife may increase women's risk of coronary heart disease.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  estradiol; free androgen index; menopause; sex hormone binding globulin

Mesh:

Substances:

Year:  2014        PMID: 24852168      PMCID: PMC4076076          DOI: 10.1194/jlr.P049064

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  37 in total

1.  The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.

Authors:  J A Cauley; J P Gutai; L H Kuller; J G Powell
Journal:  Am J Epidemiol       Date:  1990-11       Impact factor: 4.897

2.  Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution.

Authors:  G Berg; V Mesch; L Boero; F Sayegh; M Prada; M Royer; M L Muzzio; L Schreier; N Siseles; H Benencia
Journal:  Horm Metab Res       Date:  2004-04       Impact factor: 2.936

Review 3.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women.

Authors:  L H Kuller; J P Gutai; E Meilahn; K A Matthews; P Plantinga
Journal:  Arteriosclerosis       Date:  1990 Nov-Dec

6.  Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

Authors:  I F Godsland
Journal:  Fertil Steril       Date:  2001-05       Impact factor: 7.329

7.  Influence of age and menopause on serum lipids and lipoproteins in healthy women.

Authors:  J C Stevenson; D Crook; I F Godsland
Journal:  Atherosclerosis       Date:  1993-01-04       Impact factor: 5.162

8.  Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study.

Authors:  K M Anderson; P W Wilson; R J Garrison; W P Castelli
Journal:  Atherosclerosis       Date:  1987-11       Impact factor: 5.162

9.  Association of decreased sex hormone binding globulin and cardiovascular risk factors.

Authors:  S M Haffner; M S Katz; M P Stern; J F Dunn
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

10.  Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study.

Authors:  Shiyama Mudali; Adrian S Dobs; Jingzhong Ding; Jane A Cauley; Moyses Szklo; Sherita Hill Golden
Journal:  J Clin Endocrinol Metab       Date:  2004-11-16       Impact factor: 5.958

View more
  11 in total

1.  Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.

Authors:  Samar R El Khoudary; Patrick M Hutchins; Karen A Matthews; Maria M Brooks; Trevor J Orchard; Graziella E Ronsein; Jay W Heinecke
Journal:  J Clin Endocrinol Metab       Date:  2016-07-11       Impact factor: 5.958

2.  Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men.

Authors:  Katya B Rubinow; Tomas Vaisar; Jing H Chao; Jay W Heinecke; Stephanie T Page
Journal:  J Clin Lipidol       Date:  2018-04-30       Impact factor: 4.766

3.  Endogenous Sex Hormones and Endothelial Function in Postmenopausal Women and Men: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Lena Mathews; Vinita Subramanya; Di Zhao; Pamela Ouyang; Dhananjay Vaidya; Eliseo Guallar; Joseph Yeboah; David Herrington; Allison G Hays; Matthew J Budoff; Erin D Michos
Journal:  J Womens Health (Larchmt)       Date:  2019-06-06       Impact factor: 2.681

4.  Greater Periaortic Fat Volume at Midlife Is Associated with Slower Gait Speed Later in Life in Women: The SWAN Cardiovascular Fat Ancillary Study.

Authors:  Samar R El Khoudary; Xirun Chen; Alexis Nasr; Kelly Shields; Emma Barinas-Mitchell; Imke Janssen; Susan A Everson-Rose; Lynda Powell; Karen Matthews
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-11-13       Impact factor: 6.053

5.  Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?

Authors:  Meiyuzhen Qi; Xirun Chen; Ronald M Krauss; Karen Matthews; Imke Janssen; Maria M Brooks; Dan McConnell; Sybil L Crawford; Samar R El Khoudary
Journal:  Menopause       Date:  2022-07-12       Impact factor: 3.310

6.  Physiological interindividual variability in endogenous estradiol concentration does not influence adipose tissue and hepatic lipid kinetics in women.

Authors:  Faidon Magkos; Elisa Fabbrini; Bruce W Patterson; Bettina Mittendorfer; Samuel Klein
Journal:  Eur J Endocrinol       Date:  2022-07-21       Impact factor: 6.558

7.  Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL Study.

Authors:  Samar R El Khoudary; Alexis Nasr; Jeffrey Billheimer; Maria M Brooks; Dan McConnell; Sybil Crawford; Trevor J Orchard; Daniel J Rader; Karen A Matthews
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

8.  Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study.

Authors:  Alexis Nasr; Karen A Matthews; Maria M Brooks; Daniel S McConnell; Trevor J Orchard; Jeffrey Billheimer; Daniel J Rader; Samar R El Khoudary
Journal:  J Clin Lipidol       Date:  2020-07-08       Impact factor: 4.766

9.  The influence of menopause and cardiorespiratory fitness on lipoprotein particles in midlife women.

Authors:  Corinna Serviente; Melody Chalvin; Sarah Witkowski
Journal:  Appl Physiol Nutr Metab       Date:  2021-12-07       Impact factor: 3.016

10.  Metabolic Syndrome Trajectories and Objective Physical Performance in Mid-to-Early Late Life: The Study of Women's Health Across the Nation (SWAN).

Authors:  Jenna M Napoleone; Robert M Boudreau; Brittney S Lange-Maia; Samar R El Khoudary; Kelly R Ylitalo; Andrea M Kriska; Carrie A Karvonen-Gutierrez; Elsa S Strotmeyer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-02-03       Impact factor: 6.591

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.